He graduated in medicine from the Faculty of Medicine of the University of São Paulo in 1985, where he also completed a doctorate in medicine, in the area of #8203;#8203;hematology, in 1994. Currently, he works at the ABC School of Medicine, he is Full Professor of the Disciplines of Hematology and Oncology Works in a private practice in the city of São Paulo. He was elected Governor of the American College of Physician from 2010 to 2014. To date, Is the editor in chief of the Brazilian Journal of Oncology. He has published 308 full-length articles in national and international journals. He has written 63 book chapters and has 7 books published. He participated in 317 scientific events and courses in Brazil and abroad and presented more than 312 papers and lectures. He taught more than 370 classes at meetings, courses and scientific events and received 57 awards and/or honors. In his professional activities, he interacted with more than 400 collaborators in co-authorship of scientific works. He supervised 70 works at the undergraduate level, and in the postgraduate course 25 master's students and 13 doctoral students. He participated in 12 Examining Commissions for Qualification Examinations (Master's and Doctorate), 35 Judging Commissions for Dissertations and 46 for Doctoral Theses. He is a member of the editorial board of two Brazilian indexed journals (Revista da Associação Paulista de Medicina and Revista da Associação Médica Brasileira), the Cochrane Haematological Malignancies Group and the Journal of Pragmatic and Observational Research. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Gene profiling with the 21-gene panel known as Oncotype® is currently being routinely used for prognostic stratification of patients with hormone receptor-positive, HER2/neu-negative breast tumors, typically with negative axillary lymph nodes. For patients with a score above 25 in postmenopausal or 20 in premenopausal stages, Oncotype is used to indicate adjuvant chemotherapy. In addition…
Breast cancer is the leading cause of cancer mortality in women. The creation of accessible, accurate and fast biomarkers panels that allow the refining of the prognosis of these patients to better allocate the therapeutic resources is fundamental to increase the curability of this disease in its early stages before the development of detectable metastases by imaging methods. Methods that…
Cancer-related fatigue (CRF) is defined as a persistent and subjective symptoms of physical fatigue, emotional or mental exhaustion related to cancer or its treatment that may interfere with their functional capacity and is not proportional to the activities performed by the patient. Pharmacological treatment for moderate to severe fatigue may cause various side effects that preclude its …
As the result of the advances in cancer treatment, the number of cancer survivors has increased. One of the most experienced side effects by them is fatigue, a chronic sensation of tiredness, exhaustion and lack of metal e phisical energy. In some patients fatigue can persist despite of the correction of related problems (depression, amnemia, hypothyroidism, and sleep disturbances). Patie…
(Only some records are available in English at this moment)
The mechanisms of cancer metastasis are unclear and probably this is the reason why the current prognostic markers are not effective. The formation of metastasis requires the migration of tumor cells from the primary sites to other organs. Therefore, the detection of circulating tumor cells (CTC) would be useful to assess metastasis risk. However, the cells within a tumor mass present gre…
| 1 / 1 | Ongoing grants |
| 7 / 4 | Completed research grants |
| 6 / 1 | Completed scholarships in Brazil |
| 14 / 6 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID